Clinical trial
Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate…
NCT00448409 · The Methodist Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00448409 |
|---|---|
| Title | Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer |
| Official title | A Phase II Trial to Assess the Activity of TroVax® Alone vs. TroVax® Plus Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) in Patients With Progressive Hormone Refractory Prostate Cancer |
| Lead sponsor | The Methodist Hospital Research Institute, Other |
| Collaborators | Oxford BioMedica Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Biological, Drug |
| Interventions | TroVax, GM-CSF |
| Enrollment | 27 |
| Start date | May 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Mar 16, 2007 |
| Last update posted | Mar 17, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: